Testing effectiveness (Phase 2)Study completedNCT01594281
What this trial is testing
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Novartis Pharmaceuticals 107